228 related articles for article (PubMed ID: 35887377)
1. In Vivo Bio-Activation of JWH-175 to JWH-018: Pharmacodynamic and Pharmacokinetic Studies in Mice.
Tirri M; Arfè R; Bilel S; Corli G; Marchetti B; Fantinati A; Vincenzi F; De-Giorgio F; Camuto C; Mazzarino M; Barbieri M; Gaudio RM; Varani K; Borea PA; Botrè F; Marti M
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887377
[TBL] [Abstract][Full Text] [Related]
2. Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice.
Vigolo A; Ossato A; Trapella C; Vincenzi F; Rimondo C; Seri C; Varani K; Serpelloni G; Marti M
Neuropharmacology; 2015 Aug; 95():68-82. PubMed ID: 25769232
[TBL] [Abstract][Full Text] [Related]
3. JWH-018 impairs sensorimotor functions in mice.
Ossato A; Vigolo A; Trapella C; Seri C; Rimondo C; Serpelloni G; Marti M
Neuroscience; 2015 Aug; 300():174-88. PubMed ID: 25987201
[TBL] [Abstract][Full Text] [Related]
4. Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on "tetrad", sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies.
Canazza I; Ossato A; Trapella C; Fantinati A; De Luca MA; Margiani G; Vincenzi F; Rimondo C; Di Rosa F; Gregori A; Varani K; Borea PA; Serpelloni G; Marti M
Psychopharmacology (Berl); 2016 Oct; 233(21-22):3685-3709. PubMed ID: 27527584
[TBL] [Abstract][Full Text] [Related]
5. Novel halogenated synthetic cannabinoids impair sensorimotor functions in mice.
Bilel S; Tirri M; Arfè R; Ossato A; Trapella C; Serpelloni G; Neri M; Fattore L; Marti M
Neurotoxicology; 2020 Jan; 76():17-32. PubMed ID: 31610187
[TBL] [Abstract][Full Text] [Related]
6. Influence of structural characteristics on the binding of synthetic cannabinoids from the JWH family to the CB1 receptor: A computational study.
Chaturvedi K; Anthony CS; Pandey P; Doerksen RJ; Godfrey M
J Mol Graph Model; 2024 Jan; 126():108620. PubMed ID: 37722351
[TBL] [Abstract][Full Text] [Related]
7. Effect of JWH-250, JWH-073 and their interaction on "tetrad", sensorimotor, neurological and neurochemical responses in mice.
Ossato A; Canazza I; Trapella C; Vincenzi F; De Luca MA; Rimondo C; Varani K; Borea PA; Serpelloni G; Marti M
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jun; 67():31-50. PubMed ID: 26780169
[TBL] [Abstract][Full Text] [Related]
8. Synthetic cannabinoid JWH-018 and its halogenated derivatives JWH-018-Cl and JWH-018-Br impair Novel Object Recognition in mice: Behavioral, electrophysiological and neurochemical evidence.
Barbieri M; Ossato A; Canazza I; Trapella C; Borelli AC; Beggiato S; Rimondo C; Serpelloni G; Ferraro L; Marti M
Neuropharmacology; 2016 Oct; 109():254-269. PubMed ID: 27346209
[TBL] [Abstract][Full Text] [Related]
9. 5-HT
Corli G; Tirri M; Bassi M; Bernardi T; Boccuto F; Borsari M; Zauli G; Bilel S; Marti M
Eur J Pharmacol; 2024 May; 971():176486. PubMed ID: 38458413
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2/Spice: identification of novel cannabinoid receptor ligands.
Chimalakonda KC; Seely KA; Bratton SM; Brents LK; Moran CL; Endres GW; James LP; Hollenberg PF; Prather PL; Radominska-Pandya A; Moran JH
Drug Metab Dispos; 2012 Nov; 40(11):2174-84. PubMed ID: 22904561
[TBL] [Abstract][Full Text] [Related]
11. Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135.
Banister SD; Stuart J; Kevin RC; Edington A; Longworth M; Wilkinson SM; Beinat C; Buchanan AS; Hibbs DE; Glass M; Connor M; McGregor IS; Kassiou M
ACS Chem Neurosci; 2015 Aug; 6(8):1445-58. PubMed ID: 25921407
[TBL] [Abstract][Full Text] [Related]
12. Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity.
Brents LK; Gallus-Zawada A; Radominska-Pandya A; Vasiljevik T; Prisinzano TE; Fantegrossi WE; Moran JH; Prather PL
Biochem Pharmacol; 2012 Apr; 83(7):952-61. PubMed ID: 22266354
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoids in disguise: Δ9-tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles.
Wiley JL; Marusich JA; Lefever TW; Grabenauer M; Moore KN; Thomas BF
Neuropharmacology; 2013 Dec; 75():145-54. PubMed ID: 23916483
[TBL] [Abstract][Full Text] [Related]
14. MAM-2201 acute administration impairs motor, sensorimotor, prepulse inhibition, and memory functions in mice: a comparison with its analogue AM-2201.
Corli G; Tirri M; Bilel S; Arfè R; Coccini T; Roda E; Marchetti B; Vincenzi F; Zauli G; Borea PA; Locatelli CA; Varani K; Marti M
Psychopharmacology (Berl); 2023 Jul; 240(7):1435-1452. PubMed ID: 37233813
[TBL] [Abstract][Full Text] [Related]
15. Differential drug-drug interactions of the synthetic Cannabinoids JWH-018 and JWH-073: implications for drug abuse liability and pain therapy.
Brents LK; Zimmerman SM; Saffell AR; Prather PL; Fantegrossi WE
J Pharmacol Exp Ther; 2013 Sep; 346(3):350-61. PubMed ID: 23801678
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of first generation synthetic cannabinoids on binding at non-cannabinoid receptors and in a battery of in vivo assays in mice.
Wiley JL; Lefever TW; Marusich JA; Grabenauer M; Moore KN; Huffman JW; Thomas BF
Neuropharmacology; 2016 Nov; 110(Pt A):143-153. PubMed ID: 27449567
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of the designer drug and synthetic cannabinoid receptor agonist AM-2201 regarding its chemistry and metabolism.
Hutter M; Moosmann B; Kneisel S; Auwärter V
J Mass Spectrom; 2013 Jul; 48(7):885-94. PubMed ID: 23832945
[TBL] [Abstract][Full Text] [Related]
18. Pharmaco-toxicological effects of the novel third-generation fluorinate synthetic cannabinoids, 5F-ADBINACA, AB-FUBINACA, and STS-135 in mice. In vitro and in vivo studies.
Canazza I; Ossato A; Vincenzi F; Gregori A; Di Rosa F; Nigro F; Rimessi A; Pinton P; Varani K; Borea PA; Marti M
Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28597570
[TBL] [Abstract][Full Text] [Related]
19. Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors.
Rajasekaran M; Brents LK; Franks LN; Moran JH; Prather PL
Toxicol Appl Pharmacol; 2013 Jun; 269(2):100-8. PubMed ID: 23537664
[TBL] [Abstract][Full Text] [Related]
20. Moving around the molecule: relationship between chemical structure and in vivo activity of synthetic cannabinoids.
Wiley JL; Marusich JA; Huffman JW
Life Sci; 2014 Feb; 97(1):55-63. PubMed ID: 24071522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
